Humana (NYSE:HUM) Releases FY24 Earnings Guidance

Humana (NYSE:HUM) updated its FY24 earnings guidance on Wednesday. The company provided earnings per share (EPS) guidance of at least $16.00 for the period, compared to the consensus estimate of $16.17. Humana also updated its FY 2024 guidance to 16.000- EPS.

Wall Street Analyst Weigh In

A number of research firms have recently weighed in on HUM. Leerink Partners lowered Humana from an “outperform” rating to a “market perform” rating and cut their price objective for the stock from $400.00 to $250.00 in a research report on Wednesday, October 2nd. Royal Bank of Canada cut their price objective on Humana from $400.00 to $265.00 and set an “outperform” rating on the stock in a research report on Tuesday, October 8th. Cantor Fitzgerald reiterated a “neutral” rating and set a $395.00 target price on shares of Humana in a research note on Tuesday, October 1st. KeyCorp started coverage on shares of Humana in a research note on Friday, October 11th. They set a “sector weight” rating for the company. Finally, Oppenheimer lowered their target price on shares of Humana from $400.00 to $280.00 and set an “outperform” rating for the company in a research note on Thursday, October 3rd. One analyst has rated the stock with a sell rating, nineteen have given a hold rating and six have assigned a buy rating to the company’s stock. According to MarketBeat.com, the company currently has an average rating of “Hold” and a consensus target price of $315.48.

Humana Stock Performance

Shares of NYSE:HUM traded up $2.88 on Friday, reaching $260.71. The company’s stock had a trading volume of 1,396,968 shares, compared to its average volume of 1,856,202. The stock’s 50-day moving average is $297.06 and its two-hundred day moving average is $334.38. Humana has a 52-week low of $213.31 and a 52-week high of $527.18. The company has a debt-to-equity ratio of 0.67, a current ratio of 1.76 and a quick ratio of 1.66. The stock has a market capitalization of $31.39 billion, a P/E ratio of 23.09, a PEG ratio of 2.07 and a beta of 0.50.

Humana (NYSE:HUM) last announced its earnings results on Wednesday, October 30th. The insurance provider reported $4.16 EPS for the quarter, beating analysts’ consensus estimates of $3.48 by $0.68. Humana had a net margin of 1.18% and a return on equity of 13.20%. The business had revenue of $29.30 billion during the quarter, compared to analysts’ expectations of $28.66 billion. As a group, sell-side analysts forecast that Humana will post 16.06 EPS for the current year.

Humana Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, January 31st. Investors of record on Tuesday, December 31st will be issued a dividend of $0.885 per share. The ex-dividend date of this dividend is Tuesday, December 31st. This represents a $3.54 annualized dividend and a yield of 1.36%. Humana’s dividend payout ratio is currently 31.36%.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.